Does multidisciplinary rehabilitation of tortured refugees represent 'value-for-money'? A follow-up of a Danish case-study

BMC Health Services Research
Line BagerShr-Jie Wang

Abstract

The recent surge of asylum seekers in the European Union (EU) is raising questions about the EU's ability to integrate newcomers into the economy and into society; particularly those who need specialized services for the treatment of severe trauma. This study investigated whether rehabilitating traumatised refugees represents 'value-for-money' (VfM) in terms of intervention cost per health gain and in a long-term and societal perspective. The economic evaluation comprised a cost-utility analysis (CUA) and a partial cost-benefit analysis (CBA). The CUA incorporated data on Quality Adjusted Life Years (QALY) for 45 patients who were treated at the Rehabilitation and Research Centre for Torture Victims, Copenhagen, Denmark, in 2001-2004 and followed for up to 2 years, to determine the incremental cost effectiveness ratio (ICER). For the CBA, data was collected for 44 patients who completed treatment between 2001 and 2004 and 44 matched controls on the waiting list, for the patients' primary health care utilisation, and personal and family labour income from 2001 to 2014. This was analysed to evaluate the Net Social Benefit (NSB) of the programme. The average cost of treatment was found to be about 32,000 USD per patient (2016 pric...Continue Reading

References

Feb 13, 2002·Nordic Journal of Psychiatry·V Nørholm, P Bech
Apr 3, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jing-Shiang Hwang, Jung-Der Wang
Nov 20, 2004·BMJ : British Medical Journal·Joanna Coast
Aug 4, 2005·JAMA : the Journal of the American Medical Association·Grant N MarshallChi-Ah Chun
Oct 7, 2005·The Journal of Nervous and Mental Disease·Jessica Mariana CarlssonMarianne Kastrup
Aug 1, 2006·Health Policy and Planning·Franco Sassi
Jul 31, 2008·Journal of Consulting and Clinical Psychology·Kristina A HedtkeDean G Kilpatrick
Feb 12, 2010·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Alexander C McFarlane
Nov 5, 2010·The Journal of Nervous and Mental Disease·Jessica Mariana CarlssonErik Lykke Mortensen
Jan 26, 2011·International Journal of Technology Assessment in Health Care·Irina CleemputMark Leys
Aug 4, 2011·Scandinavian Journal of Public Health·Lau Caspar Thygesen, Annette Kjær Ersbøll
Sep 8, 2011·Scandinavian Journal of Public Health·Lau Caspar ThygesenHenrik Brønnum-Hansen
Apr 12, 2012·Child and Adolescent Psychiatry and Mental Health·Elena Gospodarevskaya, Leonie Segal
Sep 29, 2012·Journal of Pediatric Psychology·Adam MorrisDouglas Delahanty
Dec 18, 2013·Social Science & Medicine·Judit SimonTom Burns
Apr 15, 2014·ClinicoEconomics and Outcomes Research : CEOR·Emmanuel Kabengele MpingaPhilippe Chastonay
Jun 7, 2015·Transcultural Psychiatry·Ortal Slobodin, Joop T V M de Jong
Sep 20, 2015·Applied Health Economics and Health Policy·Emmanuel Kabengele MpingaPhilippe Chastonay
Oct 30, 2015·BMC International Health and Human Rights·Marija BogicStefan Priebe
Sep 24, 2016·Journal of Immigrant and Minority Health·Cindy C Sangalang, Cindy Vang

❮ Previous
Next ❯

Citations

Oct 26, 2018·Frontiers in Psychiatry·Matthis SchickAngela Nickerson
Feb 13, 2021·International Journal of Environmental Research and Public Health·Michael HollifieldAnnette Holland

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive behavioural therapy

Software Mentioned

Bref
DIGNITYs
WHOQOL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.